President and Chief Executive Officer · Endo International plc (ENDO)

Blaise Coleman

FY2022 is the first fiscal year CompBrief holds for Blaise Coleman as a named executive officer of Endo International; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$12,849,847

Salary $978,296Stock awards $0Bonus $11,850,000

1st of 3 named executive officers at Endo International by FY2022 total.

3 named officers on file for Endo International, FY2022

Blaise Coleman’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Endo International’s whole pay program stands against its peers

  • Endo International’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ENDO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2023 (10-K/A).

Free

Get Blaise Coleman’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Blaise Coleman compensation by year

Endo International Summary Compensation Table · the one fiscal year held
In US dollars, as Endo International reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$978,296
Bonus$11,850,000
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$21,551
Total$12,849,847

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Endo International plc 10-K/A filed April 28, 2023, accession 0001593034-23-000010, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Endo International plc filed document, accession 0001593034-23-000010. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
PSU1,342,584$93,981—
RSU226,514$15,856—

Per the Outstanding Equity Awards at Fiscal Year-End table in Endo International plc's FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Endo International’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Blaise Coleman · this pagePresident and Chief Executive Officer$12,849,847
James TursiExecutive Vice President, Global Research & Development$6,359,149
Matthew MalettaExecutive Vice President, Chief Legal Officer and Company Secretary$4,250,318

The full Endo International compensation record

free company brief

This page is one person within Endo International's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Endo International's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Blaise Coleman's compensation dossier · One-time report. No refunds.